GALMED PHARMACEUTICALS LTD. Other Asset Impairment Charges
GALMED PHARMACEUTICALS LTD. (GLMD) reported Other Asset Impairment Charges of $2.46 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2026-09-02
- GALMED PHARMACEUTICALS LTD. other asset impairment charges for the quarter ending 2025-12-31 was $1.94M.
- GALMED PHARMACEUTICALS LTD. other asset impairment charges for the quarter ending 2025-09-30 was $0.00.
- GALMED PHARMACEUTICALS LTD. other asset impairment charges for the quarter ending 2025-06-30 was $526.00K.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 6 month | Other Asset Impairment Charges 9 month | Other Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.94M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-31 | $1.94M derived: sum of 2 quarters · filed 2026-03-31 | $2.46M derived: sum of 3 quarters · filed 2026-09-02 | $2.46M 20-F · filed 2026-03-31 |
| 2025-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-11-26 | $526.00K derived: sum of 2 quarters · filed 2026-09-02 | $526.00K 6-K · filed 2025-11-26 | |
| 2025-06-30 | $526.00K 6-K · filed 2026-09-02 | $526.00K 6-K · filed 2026-09-02 | ||
| 2024-12-31 | $1.15M 20-F · filed 2026-03-31 |